Bergna M - Search Results

1

The clinical benefit of mepolizumab replacing omalizumab in uncontrolled severe eosinophilic asthma.

Chapman KR, Albers FC, Chipps B, Muñoz X, Devouassoux G, Bergna M, Galkin D, Azmi J, Mouneimne D, Price RG, Liu MC. Chapman KR, et al. Among authors: bergna m. Allergy. 2019 Sep;74(9):1716-1726. doi: 10.1111/all.13850. Epub 2019 Jul 1. Allergy. 2019. PMID: 31049972 Free PMC article. Clinical Trial.

2

Benefit of switching to mepolizumab from omalizumab in severe eosinophilic asthma based on patient characteristics.

Liu MC, Chipps B, Munoz X, Devouassoux G, Bergna M, Smith SG, Price RG, Galkin DV, Azmi J, Mouneimne D, Albers FC, Chapman KR. Liu MC, et al. Among authors: bergna m. Respir Res. 2021 May 10;22(1):144. doi: 10.1186/s12931-021-01733-9. Respir Res. 2021. PMID: 33971856 Free PMC article. Clinical Trial.

3

Dupilumab in Children with Uncontrolled Moderate-to-Severe Asthma.

Bacharier LB, Maspero JF, Katelaris CH, Fiocchi AG, Gagnon R, de Mir I, Jain N, Sher LD, Mao X, Liu D, Zhang Y, Khan AH, Kapoor U, Khokhar FA, Rowe PJ, Deniz Y, Ruddy M, Laws E, Patel N, Weinreich DM, Yancopoulos GD, Amin N, Mannent LP, Lederer DJ, Hardin M; Liberty Asthma VOYAGE Investigators. Bacharier LB, et al. N Engl J Med. 2021 Dec 9;385(24):2230-2240. doi: 10.1056/NEJMoa2106567. N Engl J Med. 2021. PMID: 34879449 Clinical Trial.

4

Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD.

Rabe KF, Martinez FJ, Ferguson GT, Wang C, Singh D, Wedzicha JA, Trivedi R, St Rose E, Ballal S, McLaren J, Darken P, Aurivillius M, Reisner C, Dorinsky P; ETHOS Investigators. Rabe KF, et al. N Engl J Med. 2020 Jul 2;383(1):35-48. doi: 10.1056/NEJMoa1916046. Epub 2020 Jun 24. N Engl J Med. 2020. PMID: 32579807 Clinical Trial.

5

Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial.

Han JK, Bachert C, Fokkens W, Desrosiers M, Wagenmann M, Lee SE, Smith SG, Martin N, Mayer B, Yancey SW, Sousa AR, Chan R, Hopkins C; SYNAPSE study investigators. Han JK, et al. Lancet Respir Med. 2021 Oct;9(10):1141-1153. doi: 10.1016/S2213-2600(21)00097-7. Epub 2021 Apr 16. Lancet Respir Med. 2021. PMID: 33872587

6

Increased exhaled breath temperature in subjects with uncontrolled asthma.

García G, Bergna M, Uribe E, Yañez A, Soriano JB. García G, et al. Among authors: bergna m. Int J Tuberc Lung Dis. 2013 Jul;17(7):969-72. doi: 10.5588/ijtld.12.0657. Int J Tuberc Lung Dis. 2013. PMID: 23743317

7

Patient perception of Breezhaler^® and Ellipta^® device feedback mechanisms in COPD: The ADVANTAGE Study.

Altman P, Bergna MA, Garcia GR, Guerin T, Pino AV, Whiteford JL. Altman P, et al. Curr Med Res Opin. 2019 Feb;35(2):221-227. doi: 10.1080/03007995.2018.1464437. Epub 2018 May 15. Curr Med Res Opin. 2019. PMID: 29649916

8

Development of a simple binary response questionnaire to identify airflow obstruction in a smoking population in Argentina.

Bergna MA, García GR, Alchapar R, Altieri H, Casas JC, Larrateguy L, Nannini LJ, Pascansky D, Grabre P, Zabert G, Miravitlles M. Bergna MA, et al. Eur Respir Rev. 2015 Jun;24(136):320-6. doi: 10.1183/16000617.00005214. Eur Respir Rev. 2015. PMID: 26028643 Free PMC article.

9

Nintedanib in Progressive Fibrosing Interstitial Lung Diseases.

Flaherty KR, Wells AU, Cottin V, Devaraj A, Walsh SLF, Inoue Y, Richeldi L, Kolb M, Tetzlaff K, Stowasser S, Coeck C, Clerisme-Beaty E, Rosenstock B, Quaresma M, Haeufel T, Goeldner RG, Schlenker-Herceg R, Brown KK; INBUILD Trial Investigators. Flaherty KR, et al. N Engl J Med. 2019 Oct 31;381(18):1718-1727. doi: 10.1056/NEJMoa1908681. Epub 2019 Sep 29. N Engl J Med. 2019. PMID: 31566307 Clinical Trial.

10

Pharmacological management of progressive-fibrosing interstitial lung diseases: a review of the current evidence.

Richeldi L, Varone F, Bergna M, de Andrade J, Falk J, Hallowell R, Jouneau S, Kondoh Y, Morrow L, Randerath W, Strek M, Tabaj G. Richeldi L, et al. Among authors: bergna m. Eur Respir Rev. 2018 Dec 21;27(150):180074. doi: 10.1183/16000617.0074-2018. Print 2018 Dec 31. Eur Respir Rev. 2018. PMID: 30578333 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

30 results

Search Page